Skip to main content

Table 1 Characteristics of COPD group

From: Assessment of osteoporosis using the FRAX method and the importance of vitamin D levels in COPD patients

Feature

Mean ± SD

Median (min–max)

Age

62.4 ± 8.3

65 (41–76)

Smoking (PY)

43.8 ± 15.7

40 (20–100)

COPD time from diagnosis

7.6 ± 5.8

5 (2–25)

FEV1(mL)

1435 ± 597

1285 (400–2720)

FVC (mL)

2516 ± 777

2360 (840–4000)

FEV1/FVC (%)

55.8 ± 9.1

57 (33–70)

BMI (kg/m2)

24.6 ± 4.8

24 (14–38.6)

MRC

1.2 ± 0.6

2.2 (0–3)

CAD

11.5 ± 4.5

11 (4–26)

Exacerbation number

0.65 ± 0.9

0 (0–4)

Hospitalization number

0.24 ± 0.4

0 (0–2)

Vitamin D

12 ± 6.6

10.9 (4.2–34.9)

FRAX score (major osteoporotic)

6.09 ± 4.2

4.7 (2.1–26)

FRAX score (hip fracture)

2.5 ± 3.3

1.6 (0.3–19)

Lumber T Score

−1.4 ± 1.5

−1.6 (−4.3–2.7)

Neck T Score

−1.6 ± 0.9

−1.7 (−4–0.6)